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As clinicians attempt to understand the underlying reasons for the vulnerability of
different regions of the developing brain to injury, it is apparent that little is known
as to how hypoxia-ischemia may affect the cerebrovasculature in the developing infant.
Most of the research investigating the pathogenesis of perinatal brain injury following
hypoxia-ischemia has focused on excitotoxicity, oxidative stress and an inflammatory
response, with the response of the developing cerebrovasculature receiving less attention.
This is surprising as the presentation of devastating and permanent injury such as
germinal matrix-intraventricular haemorrhage (GM-IVH) and perinatal stroke are of vascular
origin, and the origin of periventricular leukomalacia (PVL) may also arise from poor
perfusion of the white matter. This highlights that cerebrovasculature injury following
hypoxia could primarily be responsible for the injury seen in the brain of many infants
diagnosed with hypoxic-ischemic encephalopathy (HIE). Interestingly the highly dynamic
nature of the cerebral blood vessels in the fetus, and the fluctuations of cerebral blood
flow and metabolic demand that occur following hypoxia suggest that the response of
blood vessels could explain both regional protection and vulnerability in the developing
brain. However, research into how blood vessels respond following hypoxia-ischemia have
mostly been conducted in adult models of ischemia or stroke, further highlighting the
need to investigate how the developing cerebrovasculature responds and the possible
contribution to perinatal brain injury following hypoxia. This review discusses the current
concepts on the pathogenesis of perinatal brain injury, the development of the fetal
cerebrovasculature and the blood brain barrier (BBB), and key mediators involved with
the response of cerebral blood vessels to hypoxia.
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INTRODUCTION
The most devastating permanent injury that can occur in the
developing fetus is germinal matrix-intraventricular hemorrhage
(GM-IVH) with the incidence greater in premature and low birth
weight babies. Term infants are more susceptible to breakdown of
the blood brain barrier (BBB), brain edema, subcortical hemor-
rhage and impaired metabolism (Wigglesworth and Pape, 1978;
Van den Broeck et al., 2007). Volpe (1989) suggests that conse-
quences and subsequent neuropathology that originate fromGM-
IVH include destruction of the germinal matrix, periventricular
hemorrhagic infarction (possibly of venous origin), periventric-
ular leukomalacia (PVL), hydrocephalus and pontine neuronal
necrosis. Analysis of neonates with PVL suggest that this area of
infarct contained poorly perfused vessels of an irregular capillary
shape, suggesting a relationship between vascular supply to this
region and the pathology of PVL (Takashima and Tanaka, 1978a).
Clinicians have long sought to understand the inherent vul-
nerability of the sub-ependymal germinal matrix to hemorrhage
and periventricular white matter to necrosis. Observations of
infarctions in these periventricular areas were seen to occur in
watershed vascular or border “end zones” (areas where long and
penetrating arteries end). These areas were deemed more vulner-
able to poor perfusion and less capable of tolerating fluctuations
of cerebral blood flow and cerebral venous pressure especially
following hypoxia-ischemia and/or reperfusion (De Reuck, 1971;
Takashima and Tanaka, 1978a,b; Wigglesworth and Pape, 1978;
Volpe, 1989).
Ballabh (2010) suggests that the germinal matrix, which is
highly vascularized, may have an inherent fragility during devel-
opment deeming it vulnerable to hemorrhage, which may be
further exacerbated following hypoxia. Interestingly, Volpe (1989)
also highlights that many thin walled cerebral blood vessels are
the source of bleeding. This finding was also seen in the beagle
puppy model of germinal matrix hemorrhage (Trommer et al.,
1987; Ment et al., 1991) but not in the rhesus monkey (Lenn
and Whitmore, 1985). The observation of thin walled blood
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vessels could be indicative of structural immaturity or ongoing
angiogenesis. However, Back et al. consider that injury occurring
in periventricular white matter is more likely to be due to cellu-
lar immaturity—especially of oligodendrocyte progenitors—than
of the vascular elements within these regions (Back et al., 2007;
McClure et al., 2008).
The response of the cerebrovasculature following hypoxia-
ischemia and how this may contribute to perinatal brain injury
is not well investigated. In the adult brain, robust up-regulation
of vascular endothelial growth factor (VEGF) occurs following
cerebral hypoxia and/or ischemia which, as an adaptive response,
results in the formation of new blood vessels. However, newly-
formed blood vessels are fragile and prone to rupture. The obser-
vation of thin walled blood vessels in regions prone to bleeding
and hemorrhage (Volpe, 1989), could be indicative of structural
immaturity or ongoing angiogenesis. Incomplete development of
hypoxia-induced angiogenesis could be a major factor in the cere-
bral injury that follows the birth of a severely hypoxic fetus, or
which arises in the neonate where resuscitation is difficult and
prolonged. The response of blood vessels, changes in blood flow,
and the reactive expression of proteins by the vasculature could
be directly affected by the processes of excitotoxicity and oxidative
stress which are already known to be closely inter-related, and the
occurrence of hemorrhage and leukomalacia highlight that the
response of the vasculature is pivotal. Understanding the devel-
opment and response of the cerebrovasculature and BBB could
reveal reasons for regional vulnerability of the immature brain to
vascular damage.
PERINATAL HYPOXIA
Intrapartum asphyxia is present in up to 25 per 1000 live births in
term deliveries (Low, 2004). However, the incidence of antepar-
tum and/or intrauterine asphyxia is much more difficult to deter-
mine. Post mortem studies indicate that hypoxic-ischemic and
asphyxic episodes that occur during pregnancy significantly con-
tribute to brain injury, morbidity andmortality (Sims et al., 1985;
Low et al., 1989; Low, 2004). Intrauterine asphyxia also con-
tributes to cognitive impairment, developmental delay, epilepsy,
motor deficits and cerebral palsy (Low et al., 1989; Cowan et al.,
2003; Low, 2004; Glass et al., 2009). The Australian Cerebral Palsy
Foundation states that the incidence of cerebral palsy (approx-
imately 1 in 400 live births) has remained relatively unchanged
over the last 40 years, despite reduction in the rate of perinatal
morbidity (Stanley andWatson, 1992). This highlights the impor-
tance of understanding the contribution of intrauterine events,
such as fetal hypoxia, academia, and asphyxia to the pathogenesis
of brain injury.
Asphyxia describes an insufficiency to exchange respira-
tory gases (Stephens, 1995; Parer, 1998). The severity of
asphyxia and hypoxia-ischemia are thereby defined as a series of
cardio-respiratory changes, including hypoxia (decreased pO2),
hypercapnia (increased pCO2), hypoxemia, metabolic acidosis
(increased lactate), impaired blood gas exchange and ischemia
decreased oxygen delivery to tissue. Some argument exists over
whether “asphyxia” can be applied to events occurring during
gestation since, in the adult, asphyxia describes deficient oxy-
gen supply arising from the inability to breathe (such as seen
during strangulation). In utero the fetus does not breathe, but
fetal asphyxia does arise from insufficient umbilical or uterine
blood flow resulting in impaired blood gas exchange (Parer, 1998;
Low, 2004), and is therefore, used to describe the simultaneous
decrease in oxygen and increase in carbon dioxide levels in fetal
blood and tissues. However, without measurement of blood gases
and cardiovascular parameters, the definition of asphyxia is diffi-
cult, and in this review of fetal and neonatal pathophysiology the
terms hypoxia or hypoxia-ischemia will be used. Common causes
of hypercapnic hypoxia in the fetus include maternal infection,
hypertension, diabetes and placental insufficiency, all of which
have the tendency to reduce uterine and/or umbilical blood flows.
Fetal factors can range from multiple births, tangling or obstruc-
tion of the umbilical cord, or partial separation of the placenta
from the uterine wall. The extent of injury that can occur as a
consequence of hypoxia are dependent on the duration, degree
and frequency of the insult. The gestational age at which hypoxia
occurs also affects the brain regions involved.
PERINATAL BRAIN INJURY
Hypoxia is one of the most common causes of neonatal brain
injury, and it still remains to be well understood as to why some
brain regions are more vulnerable to injury than others. The brain
regions susceptible to hypoxic injury also change as the infant
matures (Barkovich, 2005). A possible explanation for the cor-
relation between gestational age and the type of brain injury may
be the changing location of intervascular “watershed” boundary
zones. From human infant autopsy tissue it was found the most
prominent injury that occurred was hemorrhage with areas of
necrotic tissue, and with exacerbated injury in neonates that had
suffered hypoxia-ischemia or a complicated pregnancy. A recent
study demonstrated that hypoxic-ischemic injury in term infants
resulted in subcortical hemorrhage in 13% of the subjects, while
24% of preterm infants showed IVH (Van den Broeck et al., 2007).
From studies in fetal sheep it has been shown that younger fetuses
can tolerate longer periods of complete cessation of umbilical
blood flow, up to 25min, however, near-term fetuses can only
withstand up to 10min (Mallard et al., 1994; Keunen et al., 1997).
The differing tolerance across gestation to duration is suggested
to be due to the greater tissue metabolic rate of the near term
fetus, and hence the greater response in terms of excitotoxicity,
free radical production, and propensity of mitochondrial damage
(Bennet et al., 1999). To understand the impact hypoxia has on
the developing brain, the most prominent types of brain injury
are described below.
Preterm brain injury
Premature neonates who are also of a low birth weight are at the
highest risk of PVL and GM-IVH. The source of GM-IVH was
classified by Takashima and Tanaka (1978b), Wigglesworth and
Pape (1978), and Volpe (1989) who described bleeding occurring
around the subependymal germinal matrix (around the lateral
ventricle) extending into the white matter. PVL is characterized
by hemorrhagic necrosis of the white matter surrounding the lat-
eral ventricles. It can be diffuse or focal and commonly occurs in
the preterm infant [reviewed by Volpe (1998)]. Cellular immatu-
rity of oligodendrocytes also significantly contributes to regional
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vulnerability of white matter (Alvarez-Diaz et al., 2007; Back
et al., 2007). This “selective vulnerability” governs the subsequent
manifestation of injury. Blood vessels within the germinal matrix
are fragile, particularly during the period of high cell turnover
(24–32 weeks gestation) associated with corticogenesis. At this
point of gestation, the oxygen and nutrient demand of the germi-
nal matrix is high, and the requirement for correspondingly high
blood flow appears to be met by a network of very fragile and
leaky blood vessels. GM-IVH is a common brain injury in pre-
mature infants, particularly at <30 weeks gestation, and is more
common when babies suffer additional stresses such as respira-
tory distress syndrome, pneumothorax, or high blood pressure,
although it can also occur in healthy premature and full-term
babies. IVH implies structural immaturity of blood vessels in
the germinal matrix, and is associated with deficient autoreg-
ulatory capacity and pressure-passive cerebral perfusion (Pryds
et al., 1989). Elevation of intracerebral venous pressure may be
involved, as obstructed venous drainage has been shown to be
associated with periventricular hemorrhage (Perlman, 1998).
The developmental status of the cerebral vasculature is also
thought to be a critical predisposing factor in the pathogenesis
on PVL. The topographic predilection of white matter injury is
distinct between immature and mature brains, because regional
cerebral blood flow and metabolic demand are rapidly changing
during the perinatal period. In the immature brain, the end-zones
of perforating arteries through the cerebral cortex are located in
the periventricular white matter, which is a watershed area vul-
nerable to PVL. A predisposing factor in the pathogenesis of IVH
in preterm infants is the microvascular architecture of the germi-
nal matrix, which is at the end zone of thalamo-striatal arteries
and in the venule structure zone of the ventricular side of ter-
minal vein (Takashima et al., 1978). Hypotension or hypoxemia
may induce focal hypoxic-ischemic changes in the arterial end
zone within the germinal matrix, and with reperfusion or over-
perfusion following hypoxia-ischemia, venous hemorrhage may
occur due to the paucity of supportive connective tissue (Kamei
et al., 1992). In addition, the microvasculature of the germi-
nal matrix is frail because of an abundance of angiogenic blood
vessels (Ballabh et al., 2007) that possess few pericytes, an incom-
plete and immature basal lamina, and an investment of astrocytic
processes (“end-feet”) with a deficiency of glial fibrillary acidic
protein (GFAP) (El-Khoury et al., 2006). Pericyte coverage is less
in the germinal matrix vascular bed than in cortical gray or white
matter in human fetuses, premature infants (20–28 weeks gesta-
tion) and premature rabbit pups (Braun et al., 2007), consistent
with their propensity for structural collapse and hemorrhage.
Term brain injury
Term neonates who undergo birth asphyxia or hypoxia-ischemia
late in gestation tend to have injury in the deep gray matter, hip-
pocampus, brainstem, and thalamic regions (Swarte et al., 2009).
The most common injuries are parasagittal cerebral injury, and
injuries to the basal ganglia, including thalamic bleeding with
associated IVH (Van den Broeck et al., 2007). In recent years
mild white matter injury has also been reported to occur in the
term neonate, occurring near birth (Li et al., 2009; Swarte et al.,
2009). Cowan et al. (2003) studied MRI and post mortem tissue
of full term infants and found that the period immediately pre-
ceding birth was an important time when brain injury could
arise. The vascular boundary zones in term infants lies between
the anterior and middle cerebral arteries and between the middle
and the posterior cerebral arteries. PVL and hemorrhage tend to
occur in term neonates at a lower but still significant incidence
(Wigglesworth and Pape, 1978; Inder and Volpe, 2000; Perlman,
2004; Takenouchi et al., 2012). Watershed injury can also occur
with or without deep cortical involvement (Swarte et al., 2009).
Perinatal stroke
Perinatal stroke is defined as a cerebrovascular event that can
occur between 28 weeks gestation and 28 days postnatal age.
The incidence of perinatal stroke (thromboembolism) is approx-
imately 1 in 4000 live births, with <5% also being associated
with asphyxia (Estan and Hope, 1997; Lynch et al., 2002). Clinical
studies from full term neonates that have experienced perina-
tal arterial stroke show a greater incidence of cerebral palsy,
epilepsy, language delay, behavioral abnormalities, and brain
injury to the basal ganglia, internal capsule Broca’s andWernicke’s
area. Increased stroke size also further increases the incidence of
cerebral palsy (Lee et al., 2005).
Clinical manifestation of infants who have experienced stroke
include seizure activity and apnea from the second postnatal
day (Koelfen et al., 1995; Perlman, 2004), this can also per-
sist to neonatal encephalopathy (Ramaswamy et al., 2004). Focal
stroke in the term infant is most common with the presentation
of seizure activity without associated encephalopathy. However,
if neonatal encephalopathy also occurred, neurodevelopmental
outcome significantly worsened (de Vries et al., 1997; Perlman,
2004; Ramaswamy et al., 2004).
PATHOPHYSIOLOGY OF HYPOXIA-ISCHEMIA IN THE NEONATAL BRAIN
The developing brains’ response to global hypoxia-ischemia is a
multi-step process. Within the first few hours, regionally-specific
increases of cerebral blood flow occur, followed by decreases due
to either regional vasoconstriction or the progressive collapse of
cardiac output, with the subsequent onset of excitotoxicity, energy
depletion and generation of free radicals collectively resulting in
increased apoptotic and necrotic cell death, and edema forma-
tion (Wigglesworth and Pape, 1978; Bennet et al., 1998; Jensen
et al., 1999; Shalak and Perlman, 2004; Ferrari et al., 2010a).
A secondary phase of injury occurs in the following hours and
days, resulting in a neuroinflammatory response, mitochondrial
permeabilisation, reperfusion, and a loss of cerebral autoregu-
lation which can also lead to increased free radical production
(Inder and Volpe, 2000; Hamrick and Ferriero, 2003; McLean and
Ferriero, 2004; Hagberg et al., 2009; Leonardo and Pennypacker,
2009). More recently it has been described that a tertiary phase
of brain injury, occurring in the weeks to years following an
insult, may also contribute to exacerbating injury and/or prevent-
ing repair when mechanisms such as an inflammatory response
persist (Fleiss and Gressens, 2012).
CNS excitotoxicity
Excitotoxicity refers to cell death that occurs due to intracellular
accumulation of calcium resulting from the prolonged opening
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of voltage-sensitive channels associated with excitatory amino
acid receptors (Beal, 1992). Prolonged neuronal depolarization
increases neurotransmitter release, but astrocytic re-uptake of
glutamate becomes restricted due to low availability of ATP, so
overstimulation of glutamate receptors occurs due to the presence
of excess extracellular glutamate (McLean and Ferriero, 2004)
leading, in some cases, to seizure activity (Jensen et al., 1998;
Bennet et al., 2010). Glutamate and adenosine, whose receptors
are expressed on excitatory neurons, are both implicated in exci-
tatory mediated injury following hypoxia (McLean and Ferriero,
2004). In addition, neurons are vulnerable to hypoxia-induced
injury due to their high dependence on oxygen. Neuronal glu-
tamate release, re-uptake and resynthesis is a tightly regulated
metabolic pathway that is closely coupled with cerebral glu-
cose oxidation demand. Glutamate receptors are highly expressed
during fetal and neonatal development, so any severe fluctua-
tions, such as those resulting from hypoxia can have devastating
consequences (Low, 2004; McLean and Ferriero, 2004).
Oxidative stress
Oxidative stress arises when reactive oxygen species (ROS) and/or
reactive nitrative species (RNS) are generated at a rate that exceeds
the capacity of the endogenous antioxidant systems to neutral-
ize them. The developing brain is considered to be extremely
vulnerable to free radical damage due to its high lipid content
(O’Brien and Sampson, 1965), with the amount of polyunsatu-
rated fatty acids increasing during gestation, relatively high oxy-
gen consumption and therefore, a high capacity to generate ROS,
and low concentrations and activity of the principal antioxidant
enzymes (Mishra and Delivoria-Papadopoulos, 1999; McLean
and Ferriero, 2004; Vannucci and Hagberg, 2004; Ikonomidou
and Kaindl, 2011; Miller et al., 2012). During normal metabolism
ROS are produced in low concentrations, and may act as sig-
naling molecules to modulate vasodilatation and cerebral blood
flow (Paravicini et al., 2004), but under conditions that result
in tissue hypoxia the accumulation of ROS can trigger the mito-
chondrial release of pro-apoptotic proteins resulting in cell death
(Morita-Fujimura et al., 2001). Whether ROS-mediated damage
occurs specifically to vascular elements in the developing brain is
unclear.
NO is a weak free radical, produced by the actions of nitric
oxide synthase (NOS) isoforms, and has a number of physio-
logical roles including the physiological modulation of cerebral
blood flow, modulating cellular respiration and mitochondrial
ROS production, as well as having antioxidant properties (Beltran
et al., 2000; Li and Jackson, 2002). Three well known isoforms
of NOS—neuronal NOS (nNOS), endothelial NOS (eNOS),
and inducible NOS (iNOS). iNOS is principally produced in
macrophages, microglia, endothelial cells, and astrocytes, nNOS
in neurons and eNOS primarily in endothelial cells and following
neonatal hypoxia-ischemia has been found in neurons (Ferriero
et al., 1996; McLean and Ferriero, 2004; Kaur and Ling, 2009).
Following neonatal hypoxia-ischemia both nNOS and eNOS
are up-regulated (Van den Tweel et al., 2005). Whilst nNOS
knockout mice appear to be protected following neonatal
hypoxia-ischemia (Ferriero et al., 1996), studies from eNOS
knockout mice suggest eNOS may play a protective role
hypoxia-ischemia in the adult brain (Huang et al., 1996), which
may be due to eNOS influencing neural migration and outgrowth
and acting as a downstream regulator of angiogenesis (Chen et al.,
2005). The lipid peroxidation that occurs following acute hypoxia
in the fetal brain (Ikeda et al., 1998; Castillo-Melendez et al., 2004)
may be due to the generation of peroxynitrite (OONO), follow-
ing the non-enzymatic combination of NO and superoxide (Tan
et al., 1998). Lipid peroxidation affects immature oligodendro-
cytes in particular in the preterm fetal brain (Back et al., 1998),
and may be a major factor in the white matter damage that can
arise from hypoxic insult in the developing brain (Back et al.,
1998; Baud et al., 2004).
Response of inflammatory cells
Cell death that is mediated by a neuroinflammatory response
is complex. Resident microglia are some of the first cells to
become “activated.” Amoeboid microglial cells, important for
phagocytosis in the developing brain, are found in clusters in
periventricular white matter and in close association with blood
vessels in many brain regions (Fujimoto et al., 1989; Kaur et al.,
2007). Microglia are the resident immune cells in the nervous
system, whose presence is also related to vascularization, par-
ticularly in the early developmental stages of the human brain
(Fujimoto et al., 1989). Microglia are also associated with active
myelination during development (Hutchins et al., 1992; Ling and
Wong, 1993; Kaur et al., 2007; Kaur and Ling, 2009). Activated
microglia and astrocytes migrate to ischemically damaged regions
of the brain and attempt to clean up cellular debris (Leonardo and
Pennypacker, 2009). Following hypoxia-ischemia, compromise
of the BBB (section “Compromise of the Blood Brain Barrier”)
allows the entry of macrophages and cytokines into the circu-
lation (Alvarez-Diaz et al., 2007; Leonardo and Pennypacker,
2009). Activated microglia are known to produce inflammatory
cytokines interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-
α (TNF-α), as well as ROS, and RNS (Kaur and Ling, 2009).
Circulating cytokines, which may gain increased entry into the
brain through the compromised BBB, may then exacerbate exci-
totoxicity by again stimulating glutamate release, and free radical
and NO production (McLean and Ferriero, 2004).
CEREBROVASCULAR DEVELOPMENT IN THE FETUS
Vascularization of the brain begins during embryogenesis, con-
tinues into the newborn period, and involves a tightly regu-
lated process of vasculogenesis followed by angiogenesis (Mito
et al., 1991; Breier et al., 1992; Ballabh et al., 2004a), when
endothelial cells differentiate and proliferate into avascular tissue
(Yancopoulos et al., 2000). In the human embryo intra-cerebral
blood vessels appear from 7 weeks gestation when the base-
ment membrane of the capillary network forms (Korzhevskii
and Otellin, 2000). Newly developed blood vessels are initially
large (relatively), irregular in shape, and permeable to hydrophilic
substances (Stonestreet et al., 1996), but become thinner and
uniformly shaped as the endothelial cells become more tightly
interconnected (Engelhardt, 2003).
The germinal matrix, which is abundant with angiogenic ves-
sels (Ballabh et al., 2007; Ballabh, 2010), is the source of neurob-
lasts from ∼10 weeks gestation and glioblasts (oligodendrocyte
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and astrocyte precursors) in the 3rd trimester (Wigglesworth and
Pape, 1978; Volpe, 1989). Heubner’s artery is the main vascular
channel providing nutrients to this progenitor zone surround-
ing the lateral ventricle. The germinal matrix is also a terminal
area for the medullary artery which extends through to deep
white matter (Takashima and Tanaka, 1978b; Wigglesworth and
Pape, 1978; Volpe, 1989). By 36 weeks gestation the germinal
matrix is nearly involuted when, at this time, cortical regions
are undergoing vascular development (Wigglesworth and Pape,
1978; Volpe, 1989). The processes involved in this involution are
not well understood, but could be determinants of the increased
susceptibility of the germinal matrix to rupture at this time.
The caudate and thalamus develop a distinctive network
of fine, circular capillaries in comparison to white matter
and subependymal regions, where vessels run perpendicular
to the ventricle and have an elliptical shape (Takashima and
Tanaka, 1978b). The vascular density of tissue is closely cor-
related with metabolic demand and hence, cerebral blood
flow (Miyawaki et al., 1998), and as gestation proceeds so
does vascular density, increasing in the putamen, germinal
matrix, and cortex. There are some conflicting findings about
the vascularization of the white matter, where Mito et al.
(1991) found no change of vascular density during gesta-
tion, while others suggest an increase across gestation, (Gould
and Howard, 1988; Mito et al., 1991; Miyawaki et al., 1998;
Ballabh et al., 2004a), although the change is smaller and
the blood vessel density is lower compared to other brain
regions.
ENDOTHELIAL PRECURSOR CELLS IN THE FETUS
Lineage-committed angioblasts, termed endothelial progenitor
cells (EPCs), migrate and congregate into clusters, called blood
islands, forming the primary vascular plexus from which a com-
plex microcirculation arises (Risau, 1997). In early embryogen-
esis, the vascular system develops essentially by vasculogenesis,
in which angioblasts differentiate into endothelial cells to form
a primitive capillary network, whereas angiogenesis—the sprout-
ing of capillaries from preexisting blood vessels—begins later
in embryogenesis and continues throughout fetal life (Risau
et al., 1988). EPCs were originally identified as a population
of stem cells in human peripheral blood and characterized by
the expression of CD34, kinase insert domain receptor (KDR),
and CD133 markers (Asahara et al., 1997; Peichev et al., 2000).
Subsequently, EPCs have been isolated from bone marrow, fetal
liver, and umbilical cord blood. Circulating EPCs are present
during the 2nd trimester (Gussin et al., 2002) and seen to
increase during gestational age (Sugawara et al., 2005) in preg-
nant women. Importantly, EPCs are also present in cord blood at
various stages of gestation, increasing from low levels at 24–28
weeks to higher levels at 33–36 weeks gestation, equivalent to
that found in term infants (Javed et al., 2008). Another study
investigating circulating EPCs in preterm infants with bron-
chopulmonary dysplasia also showed that EPC levels were low
at <32 weeks and increased during gestation, and extremely
preterm infants with low levels of EPCs had an increased risk
of developing bronchopulmonary dysplasia (Borghesi et al.,
2009).
ANGIOGENESIS
Angiogenesis is the process of local proliferation, migration,
and remodeling of pre-existing endothelial cells to form new
blood vessels, whilst vascular remodeling occurs when an existing
vascular network is modified by pruning and vessel enlargement
forming interconnecting branches (Yancopoulos et al., 2000;
Carmeliet, 2003). Initiation of angiogenesis occurs by the exten-
sive interplay between a variety of cells and numerous growth fac-
tors. These include fibroblast growth factor (FGF; both acidic and
basic), VEGF, platelet derived growth factor (PDGF), transform-
ing growth factor (TGF) and the angiopoietins (angpt) (Tomanek
and Schatteman, 2000). Mitogens, such as VEGF, are activated to
enhance endothelial cell migration and proliferation. Endothelial
cells migrate along newly deposited extracellular matrix tracts and
form vessel sprouts, a process that requires extracellular matrix
dissolution facilitated by the presence of proteases such as matrix
metalloproteinase (MMP). Finally, tube and basementmembrane
formation occur triggering further processes which involve the
recruitment of pericytes by endothelial cells, and the eventual for-
mation of a “mature” blood vessel (Tomanek and Schatteman,
2000). In the brain, astrocytes induce endothelial cell and per-
icyte differentiation, but pericytes appear to migrate and cover
capillary-like structures faster than astrocytes, which provide the
end-feet that eventually invest the outer wall of the blood vessel
(Ramsauer et al., 2002). Interestingly, hypoxia is a key regula-
tor of angiogenesis and affects the expression of key angiogenic
proteins.
Vascular endothelial growth factor and receptors
VEGF, first described as vascular permeability factor (VPF) (Keck
et al., 1989; Leung et al., 1989), is a key regulator of vasculogene-
sis and angiogenesis (Breier et al., 1992; Breier and Risau, 1996).
During angiogenesis, endothelial cells that express VEGF also
produce plasminogen activators and MMPs to initiate extracellu-
lar matrix degradation, the first step in angiogenesis as described
above. Subsequently, VEGF has an important role in stimulat-
ing the proliferation of endothelial cells (Breier et al., 1992).
See Figure 1 for a summary.
VEGF has six homologous family members—VEGF-A (previ-
ously referred to as VPF, and also referred to as VEGF), placental
growth factor (PIGF), VEGF-B, VEGF-C, VEGF-D, and VEGF-E.
Three high-affinity tyrosine kinase receptors also exist—VEGFR-
1 (Flt-1), VEGFR-2 (fetal liver kinase (Flk-1) in the mouse/KDR
in the human) and VEGFR-3 (Flt-4), and are highly expressed on
endothelial cells (Breier et al., 1992; Breier, 2000; Carmeliet and
Storkebaum, 2002). VEGF-A is the most active, through binding
to VEGFR-1 and VEGFR-2 it is involved in blood vessel growth,
endothelial cell mitogenesis, vasodilatation (via NO dependent
pathways) and vascular permeability (Leung et al., 1989; Breier
et al., 1992; Breier, 2000; Dimberg et al., 2010). VEGF-A has seven
known isoforms; 121, 145, 148, 165, 183, 189, and 206 (Dvorak
et al., 1995; Hoeben et al., 2004). It is the most widely studied
of the VEGF family, and in this review article (to keep consistent
with the studies referenced), the use of VEGF refers to VEGF-A,
unless otherwise stated.
During embryogenesis, the formation of new blood vessels
is largely guided by the actions of VEGF through binding with
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FIGURE 1 | Diagram summarizing the actions of VEGF. VEGF is involved in
numerous important physiological processes. Angiogenesis is the main
function of VEGF, however, it also has protective actions (shown in blue) which
include neurogenesis and involvement during development, and detrimental
actions (shown in red) including being a pro-inflammatory mediator, vascular
permeability factor and involved in tumor growth.
VEGFR-2—responsible for both vascular and neuronal devel-
opment (Carmeliet, 2003). VEGF and VEGFR-2 activation is
also important for promoting neuronal growth, migration, mat-
uration, and survival, and for axonal and dendritic outgrowth
(Hermann and Zechariah, 2009; Sentilhes et al., 2010). VEGF
is expressed by the embryonic neuroectoderm, the epithelium
of the stem cell and progenitor regions of the brain. It has
been suggested that during development VEGFR-1 may act as a
decoy receptor, but it is a functionally important receptor iso-
form in the adult, as shown by the effects of hypoxia on the adult
rodent cerebral vasculature (Marti and Risau, 1998). VEGF-B
and VEGF-C isoforms are present in the brain early in embry-
onic life (Lagercrantz et al., 1998) and VEGF-C, through binding
with VEGFR-3, has recently been shown to be important in the
E15.5–18.5mouse by stimulating growth of non-vascular progen-
itor cells, such as oligodendrocyte progenitors in the optic nerve
(Alonso et al., 2011).
In the developing brain, the temporal and spatial expression
of VEGF is correlated closely with vascularization and endothe-
lial cell growth (Breier et al., 1992), and high expression by
many cell types (neuroblasts, neuroepithelial, radial glia, astro-
cytes, pericytes, and endothelial cells) may be a signal coinciding
with increasing neuronal metabolism that initiates angiogenesis
(Virgintino et al., 2003; Rosenstein and Krum, 2004; Sentilhes
et al., 2010). Increased glial VEGF expression occurs as stabi-
lization of the cerebrovasculature is reached, when glial end-feet
ensheath blood vessels (Ogunshola et al., 2000).
From 9 weeks gestation, VEGF is strongly expressed in the
developing human telencephalon (Virgintino et al., 2003), and
from 14 weeks there is strong expression of VEGF and VEGFR-
2 by neurons, glia, and blood vessels throughout the brain and
cerebellum. During 21–34 weeks gestation VEGF is also strongly
expressed in the cortex and white matter (Arai et al., 1998), and by
34 weeks neurons, astrocytes, and endothelial cells weakly express
VEGF (Sentilhes et al., 2010). Figure 1 summarizes the numerous
suggested physiological actions of VEGF.
Angiopoietins
Working in close conjunction with VEGF are the angpt and their
ligand receptors Tie (−1 and −2), part of the tyrosine receptor
kinases. There are four members of the angpt family, with angpt-
1 and angpt-2 the most fully characterized (Yancopoulos et al.,
2000; Carmeliet, 2003; Otrock et al., 2007; Hansen et al., 2008).
Apart from the known significance of angpt-1 and angpt-2 in
tumor growth, in the brain angpt-1 is important for stimulating
vessel growth and branching, and is expressed by endothelial cells,
astrocytes, and pericytes (Yancopoulos et al., 2000; Carmeliet,
2003; Kim et al., 2008). Angpt-1 knockout mice develop a normal
vasculature but are incapable of adequate vascular remodeling.
In contrast, angpt-1 over-expression leads to a functional vascu-
lature, but with limited permeability (Suri et al., 1996; Thurston
et al., 1999; Yancopoulos et al., 2000), suggesting that angpt-1may
be important for inhibiting vascular permeability.
Angpt-1 also has anti-inflammatory effects, particularly in
limiting inflammation-induced vascular leakage and inhibiting
neuronal apoptosis (Thurston et al., 1999, 2000; Valable et al.,
2003; Hansen et al., 2008). Increased expression of angpt-1 pro-
motes the “tightening” of vessels by increasing expression of tight
junction proteins and decreasing permeability and plasma leak-
age (Thurston et al., 1999, 2000; Valable et al., 2005). Angpt-1
is also implicated in promoting endothelial cell survival, migra-
tion, and enhancing the interaction between endothelial cells and
neighboring cells that result in the recruitment of pericytes (Suri
et al., 1996).
Angpt-2, important in initiating vascular remodeling, has
both agonist and antagonist actions to angpt-1 when binding
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to Tie-2, and co-expression with VEGF may dictate the func-
tion of angpt-2, determining whether vessel remodeling, vessel
regression occurs (Maisonpierre et al., 1997; Beck et al., 2000;
Yancopoulos et al., 2000; Gale et al., 2002). Over-expression
of angpt-2 can lead to defective vascular remodeling, as for the
angpt-1 knockout mouse (Maisonpierre et al., 1997), and high
angpt-2 expression in the absence of VEGF can result in ves-
sel regression, as seen following hypoxia and in tumor growth
(Holash et al., 1999; Beck et al., 2000). Expressed mostly by
endothelial cells, angpt-2 has been seen to degrade the extra-
cellular matrix and disrupt junctions between endothelial cells
in tumor vessels (Gale et al., 2002; Carmeliet, 2003). In the
adult mouse brain the presence of angpt-2 and VEGF resulted in
increased microvascular density, increased MMP-9 and decreased
zona occludin (ZO) expression, leading to increased BBB perme-
ability (Zhu et al., 2005).
THE BASEMENT MEMBRANE
The basement membrane (also commonly referred to as the basal
lamina) exists between endothelial cells and astrocytes (del Zoppo
and Mabuchi, 2003). In the brain, it is functionally important in
restricting extravasation of protein rich fluids and blood com-
ponents into the parenchyma (Hamann et al., 1996; Scholler
et al., 2007). The basement membrane is composed of collagens
and non-collagen glycoproteins (including laminin, and fibrino-
gen), glycosamineglycans and proteoglycans (heparin sulphate).
A direct consequence of the binding of collagen IV and laminin is
the tissue support it provides the basement membrane (Charonis
et al., 1985; Yurchenco and Schittny, 1990; Hamann et al., 1995;
Lukes et al., 1999; Jakobsson et al., 2008). Ment et al. (1991)
suggested that basement membrane proteins (laminin and col-
lagen IV) are important in providing structural integrity to blood
vessels, particularly in the germinal matrix (subventricular zone)
to prevent rupture. Changes in expression are also seen to occur
following ischemia (section “Degradation of Basal Lamina”).
Laminin is a non-collagenous constituent of the basement
membrane and during development its presence is closely related
to the functional and structural maturation of blood vessels
(Timpl et al., 1979; Risau and Lemmon, 1988). Laminin is made
up of a family of heterotrimeric glycoproteins containing one
of 5α, 3β, or 3γ chains, with α-chains being highly bioactive
and important in vascular development (Veltkamp et al., 2006;
Jakobsson et al., 2008). Normally, laminin expression is confined
to the basement membrane, but during development laminin
expression is also present in endothelial cells and neuronal and
glial precursors, and reactive astrocytes in response to injury
(Liesi et al., 1984; Liesi, 1985; Wagner et al., 1997). Angiogenesis
is associated with up-regulation of laminin expression and sig-
naling (Risau and Lemmon, 1988; Milner and Campbell, 2002).
Regional and time-related variations of expression of the α1, α4,
and α5 isoforms in germinal matrix, gray and white matter of
both human tissue and rabbit pups may reflect different rates of
local angiogenesis (Xu et al., 2008).
Collagen IV is derived from a triple helical molecule, [α1(IV),
2α2(IV)] (Sanes et al., 1990; Yurchenco and Schittny, 1990; Ment
et al., 1991) and plays a fundamental role in the maintenance of
integrity and function of blood vessels, particularly when there is
increased metabolic demand (Poschl et al., 2004). Studies from
knockout mice suggest collagen IV is not important until embry-
onic day 10, while other studies indicate it is important earlier
in development, possibly influencing neurite outgrowth (Laurie
et al., 1980; Poschl et al., 2004).
Fibronectin is expressed highly during developmental angio-
genesis and is essential during embryogenesis (George et al.,
1993). Fibronectins are a family of glycoproteins, and important
constituents of the basement membrane, promoting endothelial
cell adhesion, migration, and organization of the cytoskeleton
(Wang and Milner, 2006).
THE BLOOD-BRAIN BARRIER
The cerebral vascular system has anatomical and physiological
barriers that regulate the transfer of compounds into the brain.
The major functions of the BBB include protection of the brain
from the chemical environment of blood, selective transport of
substances into and out of the brain, and metabolism of blood
and brain substances (Risau andWolburg, 1990). The structure of
the BBB is composed of capillary endothelial cells, tight junctions,
astrocytes, pericytes, and the basement membrane, collectively
referred to as the neurovascular unit (Saunders et al., 2008; Abbott
et al., 2010). The anatomical barrier lies in the tight junctions
that exist between endothelial cells (Brightman and Reese, 1969)
that transform into a continuous cellular layer which is special-
ized to protect the brain. Surrounding the endothelial cells is a
basement membrane, pericytes and the astrocytic end-feet that
also contribute to barrier function (see below). To complement
the cerebrovascular barrier, is a barrier at the epithelial level
of the choroid plexus that constitutes the blood-cerebrospinal
fluid (CSF) barrier with many similar functions to the BBB. The
barrier forming cells at both these barriers also encompass a num-
ber of enzymatic systems such as the cytochrome-P450/phase II
enzymes, complemented by efflux transporters, which inactivates
and reduce the entry of potentially neurotoxic compounds into
the brain (Ek et al., 2012). At the same time, nutrients necessary
for brain function such as amino acids and glucose are actively
transported into the brain.
Barrier properties seem to be established in cerebral vessels as
soon as they grow into the brain in early development as tight
junctions are formed at this stage (Bauer et al., 1993). However,
there has been some debate to the level of maturity and restric-
tiveness of the barriers in the developing animal. While there
have been studies showing less complex tight-junctions in the
embryo (Kniesel et al., 1996), others have shown that the tight-
junctions are functional early in development (Ek et al., 2003,
2006; Daneman et al., 2010). However, it may be more helpful
to view the BBB in relation to the different needs for a develop-
ing brain than a simple issue of being less or more restrictive.
The developing brain barriers have been shown to be different
in many aspects to the adult barriers and include a fetal specific
ependymal barrier (Fossan et al., 1985), higher inward transport
of both glucose (Cornford and Cornford, 1986) and amino acids
(Braun et al., 1980; Tuor et al., 1992) into the developing brain
as well as developmental changes in the complement and expres-
sion of drug efflux transporters (Ek et al., 2010). However, there
are still many undetermined functional aspects of the developing
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blood-CSF/brain barriers. Some of these differences may very well
make the developing brain more vulnerable to various insults, in
fact, sheep studies have shown that the BBB becomes less sus-
ceptible to hyperosmolaric stress with development (Stonestreet
et al., 2006). In rodents the BBB also appears more vulnerable
to hypoxia-ischemia at early stages of development (Muramatsu
et al., 1997).
Tight junctions and adherence junctions
A tight junctional complex exists between the cerebral endothelial
cells. They provide a critical structural component that impedes
the diffusion of molecules from the blood vessel lumen into the
brain parenchyma and are composed of both cytoplasmic pro-
teins (e.g., ZO-1 and 2) and transmembrane proteins such as
claudins and occludin (Ballabh et al., 2004b, 2005; Kaur and Ling,
2008). There are also adherence junctions located near endothe-
lial cells holding neighboring cells together. They are composed
with cadherin-catenins complex and their associated proteins
(Schulze and Firth, 1993).
The claudin family consists of 24 members that bind to each
other on adjacent endothelial cells to form a primary seal of
tight junctions (Furuse et al., 1999), with claudin-1 and claudin-5
being highly expressed in cerebral capillaries (Furuse et al., 1999).
Claudin-5 is expressed as early at 12 weeks gestation in the telen-
cephalon of the human fetus (Virgintino et al., 2004), and only
claudin-5 (not claudin-1) is consistently expressed from 16 to 40
weeks gestation in the developing human brain (Ballabh et al.,
2005).
Occludin is highly expressed by brain capillary endothelial
cells, and their presence is related to increased electrical resistance
across the barrier. Occludins appear to be able to alter paracel-
lular permeability with increased expression being indicative of
greater barrier properties (Furuse et al., 1993; Hirase et al., 1997).
Occludin is expressed as early as 12 weeks gestation in the devel-
oping human brain with no change in expression for the duration
of pregnancy (Virgintino et al., 2004; Ballabh et al., 2005). These
findings show that key tight junctional proteins are present early
in human development and imply that functional tight junctions
are in place.
There are also a number of other junctional adhesion
molecules (JAMs) that are important for tight junction assembly
and integrity (Martin-Padura et al., 1998; Bazzoni, 2003). Three
JAM proteins exist: JAM-1, JAM-2, and JAM-3, although JAM-2
has not been seen to be expressed in cerebral blood vessels to date
(Aurrand-Lions et al., 2001). Ballabh et al. (2005) found JAM-1,
but not JAM-2 or JAM-3, was expressed from 16 weeks, with no
change of expression across gestation. The most abundant cyto-
plasmic accessory group of proteins are ZO, important for the
structural support of tight junctions (Stevenson et al., 1986).
Astrocytes and pericytes
Astrocyte end-feet ensheath blood vessels in the brain, separated
from the endothelial cell plasma membrane only by the basement
membrane (Risau andWolburg, 1990; Risau, 1991; Bernstein and
Karp, 1995; El-Khoury et al., 2006). This “glial sheath” is impor-
tant for cerebral vascular structure and function (Bradbury, 1984;
Willis et al., 2004). Regions with a discontinuous ensheathment
of astrocytes show incomplete or disintegrated basement mem-
brane in vitro (Wolff et al., 1974). Absence of the endothelial
cell-astrocyte interaction produces areas that are more perme-
able, such as the circumventricular regions in the hypothalamus
and brainstem (Coomber and Stewart, 1984; Goldstein, 1988;
Hamm et al., 2004). El-Khoury et al. (2006) investigated astro-
cyte end-feet coverage in the germinal matrix, white matter and
cortex of human fetuses from 16 to 40 weeks gestation using
GFAP (a cytoskeleton protein forming the intermediate filament),
S-100β (cytosolic calcium binding protein), and aquaporin-4
(AQP4; water channel protein). Remarkably, they found that
in the germinal matrix, a region vulnerable to hemorrhage in
preterm infants, relatively fewer end-feet and astrocyte processes
were labeled with GFAP or S-100β, although this did increase
across gestation. The cortex and white matter showed strong
perivascular coverage from 16weeks gestation. However, it should
be noted that although astrocyte-endothelial cell contacts are
present from very early in brain development, the presence of
barrier properties including tight junctional proteins appear to
precede these contacts (Daneman et al., 2010), making it more
likely that these contacts have regulatory roles at the BBB.
Pericytes are cells that wrap around endothelial cells and pro-
vide structural support, stability, and integrity to the vessel wall
(Ballabh et al., 2004b; Nakagawa et al., 2007; Kaur and Ling,
2008). Important in vasculogenesis, pericytes are recruited to
endothelial cells and are important for both blood vessel and
BBB development (Balabanov and Dore-Duffy, 1998). Pericytes
are present in the cerebrovasculature from as early at 10 weeks
gestation. In comparison to the cortex and white matter, the
germinal matrix has fewer pericytes present throughout gesta-
tion (Povlishock et al., 1977; Braun et al., 2007), a feature that
may be related to the vulnerability of the germinal matrix to
hemorrhage in preterm neonates. A distinctive feature of peri-
cytes is their pluripotency, as they exhibit multipotential stem
cell activity, phagocytic activity and even express macrophage
markers (Balabanov et al., 1996; Dore-Duffy et al., 2006; Bautch,
2011). Findings by Daneman et al. (2010) have clarified the role
of the pericytes at the BBB in the developing animal. PDGFR-B
null mice have reduced pericyte coverage of cerebral vessels, and
this is associated with higher BBB permeability due to increased
endothelial vesicular trafficking.
Functionally, pericytes may also be involved in cerebral
autoregulation (Hamilton et al., 2010) as they express recep-
tors for, and are modulated by catecholamines, endothelin-1,
and vasopressin (van Zwieten et al., 1988; Elfont et al., 1989;
Dehouck et al., 1997; Balabanov and Dore-Duffy, 1998; Ballabh
et al., 2004b). Pericytes and endothelial cells communicate via
gap junctions and their interaction is important for induction
of the contractile function that ultimately modulates cerebral
blood flow; for detailed reviews see (Hirschi and D’Amore, 1996;
Balabanov and Dore-Duffy, 1998; Bergers and Song, 2005; Dore-
Duffy, 2008).
CONSEQUENCE OF HYPOXIA ON CEREBRAL BLOOD
VESSELS
During development any perturbations, such as hypoxia, can sig-
nificantly alter the expression of key angiogenic genes (Ment et al.,
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1997; Mu et al., 2003; Kaur et al., 2006a; Keogh et al., 2007) and
could thereby result in a dysfunctional vascular system. In the
adult brain, severe hypoxia-ischemia such as that seen in stroke
may result in breakdown of the endothelial-dependent BBB and
physical destruction of the capillary bed, resulting in tissue reac-
tions that include angiogenesis, neovascularization and vascular
remodeling (del Zoppo andMabuchi, 2003), responses that could
be seen to be reparative and even neuroprotective. However, the
effects of hypoxia on cerebral blood vessels in fetal life has not
been widely investigated. Much of what we know is from adult
rodent studies and is detailed below.
ENDOTHELIAL PROGENITOR CELLS
In response to hypoxia-sensitive molecular cues, new blood
vessel formation, in the adult brain at least, is thought to
occur exclusively from angiogenesis. In many adult tissues,
hypoxia also induces an inflammatory response within the
vessel wall, with subsequent recruitment of circulating EPCs
contributing significantly to structural remodeling of the vas-
cular bed. With the discovery of EPCs, it has now been
shown that neovascularization after focal cerebral ischemia
can also occur via vasculogenesis—the de novo process of
blood vessel formation by differentiation and migration of
EPCs in response to local cues. EPCs can home to local tis-
sue injury and participate in damage repair or wound heal-
ing by secreting a number of growth factors that result in
neovascularization.
Moreover, systemic administration of cord blood-derived
EPCs in adult mice results in significant reduction of infarct vol-
ume, decreased neutrophil infiltration, and increased focal blood
flow at 48 h after the ischemic insult (Ohta et al., 2006). EPCs
have been shown to home to the ischemic core and promote
both cerebral neovascularization and neuronal progenitor cell
migration and survival (Zhang et al., 2002a), thereby improving
cortical expansion after cell transplantation (Taguchi et al., 2004).
Furthermore, the pre-existing level of circulating EPCs correlate
inversely with cerebral infarction, and positively correlate with
regional cerebral blood flow in patients with cerebral ischemia
(Ohta et al., 2006), suggesting that EPCs have a functional pre-
dictor value for how the cerebral vasculature will be affected by
hypoxia-ischemia. Indeed, the level of circulating EPCs and their
migratory activity can serve as a marker for the risk of a number
of cardiovascular diseases, and as a predictor of vascular function
in many diseases (Sen et al., 2011).
Recently, bone marrow-derived EPCs have been shown to
be mobilized, recruited and incorporated into ischemic tissue,
resulting in neovascularization of ischemic foci in the brain.
Furthermore, low circulating EPC level have been found to be
predictive of severe neurological impairment by 48 h post-insult,
and of the major adverse clinical outcomes on day 90 after acute
ischemic stroke, consistent with the finding that increased levels
of circulating EPCs after acute ischemic stroke are associated with
good functional outcome and reduced infarct growth (Sobrino
et al., 2007). Furthermore, hyperoxia impairs EPC signaling and
decreases in vitro proliferation of EPCs from preterm infants
(Fujinaga et al., 2009), decreases vessel density and reduces of
circulating EPCs levels in neonatal mice (Balasubramaniam and
Del Bigio, 2006), suggesting that oxygen therapy in the newborn
period could impair the physiological actions of EPCs.
HYPOXIA-INDUCED ANGIOGENESIS AND VASCULAR REMODELING
In the adult, chronic hypoxia induces angiogenesis, presum-
ably a response aimed at increasing vascularization and oxygen
delivery to oxygen-deprived tissue (Shweiki et al., 1993). This
process occurs in tumor growth (Kim et al., 1993; Breier and
Risau, 1996; Banerjee et al., 1997; Breier, 2000), wound healing
(Bates and Jones, 2003; Otrock et al., 2007), diabetic retinopa-
thy (Boulton et al., 1998; Aiello, 2005), and following stroke
(Krupinski et al., 1994; Zhang et al., 2000; del Zoppo and
Mabuchi, 2003). Neovascularization and vascular remodeling are
tightly regulated processes, and in the brain there is a complex
interplay of multiple genes; e.g., hypoxia inducible factor-1 (HIF-
1α), VEGF and erythropoietin (Epo) expressed by different cell
types (Marti et al., 2000). Following stroke, regions of high angio-
genesis have also been correlated with increased neuronal survival
(Krupinski et al., 1994). Although hypoxia-induced angiogene-
sis is thought to be a protective in the sense that more oxygen is
delivered to hypoxic-ischemic tissue, there are associated effects
such as alterations in BBB permeability that are not necessarily
beneficial (see below). Several key molecules for regression and
re-growth of capillary blood vessels have been identified includ-
ing VEGF, Placental Growth factor, acidic-FGF, TNF-α, IL-8, and
angpts. The consequence of hypoxia-induced angiogenesis in the
fetal and neonatal brain is yet to be fully determined.
Angiogenic remodeling refers to the process by which this
initial network is modified, through both pruning and vessel
enlargement in order to form the interconnecting branching pat-
terns characteristic of the mature (stable) vasculature. During
this time, vessel walls also “mature” in the sense that endothe-
lial cells become tightly integrated with supporting cells such as
smooth muscle cells and pericytes, and with the surrounding
matrix. A different process, referred to as angiogenic sprouting,
involves the formation of new vascular tubes from existing ves-
sels and their penetration into new vascular territory, and this
involves degradation of the existing vessel, and the formation
of new structures which, being initially incomplete, can be said
to be “immature.” The degradation and destabilization of blood
vessels, which includes degradation of the basal membrane and
extracellular matrix, and also pericyte detachment, can lead to
BBB disruption, edema formation, and mechanical rupture, and
thus bleeding. The cellular and molecular processes involved vary
and depend on the cellular composition of vessels as well as on
local environmental factors. Each of the resident vascular cell
types (i.e., pericytes, endothelial, smooth muscle) undergo site-
and time-dependent changes in proliferation, matrix protein pro-
duction, expression of growth factors, cytokines, and receptors,
and each resident cell type plays a specific role in the overall
remodeling response. However, effects of hypoxia on, and vascu-
lar responses to fetal hypoxia that cause brain damage are poorly
understood.
HYPOXIA INDUCIBLE FACTORS
In response to hypoxia, HIF-1, a key regulator of oxygen
homeostasis is transcriptionally activated to improve oxygen
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availability (Semenza, 2009b). Increased HIF-1α also contributes
to increased expression of angiogenic genes, including VEGF,
angpt-2, PDGF-B, and PIGF (Fan et al., 2009; Semenza, 2009b).
The robust up-regulation of these genes may act as possible
biomarkers in the neonate of a previously undetected hypoxic-
ischemic event in the fetus prior to delivery.
Composed of α and β subunits, once in the nucleus, HIF-
1α dimerises with HIF-1β and binds to target genes (including
Epo and VEGF) at their hypoxia response element (Semenza,
2009b). Three alpha isoforms exist; HIF-1α, HIF-2α, and HIF-
3α, although less is known about the actions of the 2α and 3α
isoforms compared to HIF-1α. HIF-1α is expressed in many cell
types throughout the body whereas, and perhaps importantly for
the current discussion, expression of HIF-2α is restricted to vas-
cular endothelial cells (Wiener et al., 1996; Semenza, 2009b; Skuli
et al., 2009).
During embryonic and fetal brain development physiological
hypoxia stimulates vasculogenesis and angiogenesis, mediated by
HIF (Trollmann and Gassmann, 2009). HIF-1α knockout mice
show impaired erythropoiesus (among other impairments) and
die by embryonic day 8.5 (Iyer et al., 1998; Semenza, 2009a). HIF-
2α endothelial deletion shows normal development, but increased
vascular permeability, and decreased angpt-2 expression and
angiogenesis (SkuLi et al., 2009). It is therefore, suggested that
in endothelial cells, HIF-1α may be important for prolifera-
tion, metabolism, and survival, whereas HIF-2α could trigger
cell migration, adhesion and vascular integrity (Skuli and Simon,
2009).
Following hypoxia in the neonatal brain, HIF-1α predomi-
nantly accumulates first in neurons, perhaps because they are
most sensitive to fluctuations in oxygen, but sustained high
expression of HIF-1α in neurons has been shown to be protective
and anti-apoptotic (Fan et al., 2009; Trollmann and Gassmann,
2009). Following neonatal hypoxia-ischemia, mice who had a
genetic neuronal knockdown of HIF-1α had worse injury com-
pared to wild type controls (Sheldon et al., 2009). However,
inhibition of HIF-1α soon after hypoxia-ischemia has been shown
to decrease infarct size, attenuate BBB permeability changes and
neuronal death in neonatal rats (Chen et al., 2008), indicating that
the actions of HIF-1α are time-dependent.
IMPLICATIONS OF VEGF
The responseofVEGF followinghypoxia and/orhypoxia-ischemia
has been widely studied in the adult (Cobbs et al., 1998; Lennmyr
et al., 1998; Plate et al., 1999; Marti et al., 2000; Zhang et al., 2000,
2002b;Sunetal., 2003)and toa lesser extent in thedevelopingbrain
(Mentetal., 1997;Araietal., 1998;Muetal., 2003;Kauretal., 2006a;
Alyetal.,2009).Aspreviouslydescribed,apotentstimulatorandkey
transcriptional regulator of VEGF expression is HIF-1α (Forsythe
etal.,1996;MartiandRisau,1998).However,itwasrecentlyobserved
that the up-regulation of VEGF in astrocytes following hypoxia is
not entirely HIF-1α-dependent (Schmid-Brunclik et al., 2008),
and others have shown that peroxisome-proliferator-activated
receptor-gamma coactivator-1alpha (PGC-1α) induces VEGF
expression-independentlyofHIF-1α (Aranyetal., 2008).Hypoxia-
induced VEGF expression in the brain can have both neuropro-
tective and neurotoxic actions (Figure 2). This has been recently
reviewed by several authors (Carmeliet and Storkebaum, 2002;
Skold and Kanje, 2008; Hermann and Zechariah, 2009) and is
briefly summarized below.
Neurotoxic actions of VEGF
Increased circulating serum VEGF from umbilical cord blood of
infants who had experienced birth asphyxia was strongly cor-
related with hypoxic-ischemic encephalopathy (HIE) and lower
Apgar scores (Aly et al., 2009). Elevated circulating VEGF from
CSF and placenta samples was also shown to have a strong pos-
itive correlation with severity of HIE (Trollmann et al., 2003;
Vasiljevic et al., 2011). Arai et al. (1998) also found increased
astrocytic and endothelial expression of VEGF in the foci of
necrosis in infants who suffered PVL. From postnatal rat studies
of either hypobaric (chronic or acute) hypoxia or middle cere-
bral artery occlusion (MCAO), increased VEGF expression was
seen as quickly at 3 h following the insult to being sustained for
up to 7 days (Ment et al., 1997; Ogunshola et al., 2000; Mu et al.,
2003; Kaur et al., 2006a). Following hypobaric hypoxia in neona-
tal mice, high VEGF expression is seen together with increased
eNOS, iNOS, and nNOS expressions, suggesting a contribution of
nitrogen free radicals to both cerebral vasodilation and excitotox-
icity (Kaur and Ling, 2009). Astrocytic and neuronal expression
of VEGF is high following hypoxia when compared to normoxic
controls, high neuronal VEGF expression following hypoxia is
also seen in the adult (Marti and Risau, 1998; Ogunshola et al.,
2000).
The most profound consequence of increased VEGF expres-
sion is the increased vascular permeability, leading to vasogenic
edema and the leakage of blood-borne substances into the brain
parenchyma (Schoch et al., 2002; Kaur et al., 2006b). In adult
models of global hypoxia, focal cerebral ischemia and brain
trauma, increased BBB leakage was associated with acute up-
regulation of VEGF (Nag et al., 1997; Zhang et al., 2000, 2002b;
Schoch et al., 2002; Kaur et al., 2006b), and the increased expres-
sion of VEGF in astrocytes is suggested to contribute to this BBB
leakage (Schmid-Brunclik et al., 2008). Intravenous administra-
tion of VEGF in the newborn mouse has also shown to open the
BBB within 2 h (Young et al., 2004). VEGF has a direct action on
endothelial cells and pericytes, and pericytes have been implicated
in exacerbating disruption of the BBB (Hippenstiel et al., 1998;
Yamagishi et al., 1999; Al Ahmad et al., 2009; Thanabalasundaram
et al., 2010), possibly because they are amongst the first cells
to respond by moving away from the blood vessel wall, and
by producing factors such as VEGF which are thought to con-
tribute to vascular instability (Gonul et al., 2002; Al Ahmad
et al., 2009; Thanabalasundaram et al., 2010). In brain microvas-
cular endothelial cells, the disruption and disassembly of tight
junction proteins occludin and ZO-1 is VEGF mediated (Wang
et al., 2001). Fischer et al. (2002) also found that VEGF mediates
changes in ZO-1 expression following hypoxia.
Neuroprotective actions of VEGF
Hypoxia-induced angiogenesis occurs in an attempt to increase
vascularization, to increase cerebral blood flow, and oxygenation
in ischemic tissue. VEGF can increase the survival of endothe-
lial cells as well as stimulate and sustain neurogenesis and inhibit
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FIGURE 2 | Schematic diagram of the effects of VEGF following hypoxia.
Following hypoxia, increased VEGF expression stimulated angiogenesis
leading to increase vascularization. Increased VEGF expression can have
detrimental effects (shown in red) which can lead to edema and haemorrhage
formation. Beneficial effects of increased VEGF (shown in blue) help
stimulate neurogenesis, decrease apoptosis and are neuroprotective.
apoptosis (Gora-Kupilas and Josko, 2005). Schmid-Brunclik et al.
(2008) also found that following hypoxia VEGF contributes to
astrocyte proliferation and survival.
Experimental studies from the adult brain suggest that the
“early” up-regulation (between 1 h and 3 h post-MCAO) of VEGF
could be associated with alterations in BBB permeability and
contribute to exacerbating injury. The neuroprotective actions of
VEGF including neovascularization and neuronal protection are
more likely to occur in the days (after 48 h) following hypoxia
(MCAO), when both VEGF and VEGFR-2 have been shown to
be up-regulated (Marti et al., 2000). Most interestingly, it is stud-
ies that use VEGF treatment that show the best neuroprotective
outcome. In both neonatal and adult models following hypoxia,
intra-cerebroventricularly injection of VEGF resulted in reduced
gross brain injury, subsequently alleviating the decrease in brain
weight (i.e., decreased infarct volume), decreased apoptotic cells
without increasing BBB permeability. Both studies suggest this
is related to the activation of the Akt/ERK pathway (Kaya et al.,
2005; Feng et al., 2008). Inhibition of VEGFR-2 has also been
shown to decrease endothelial cell proliferation, increase cell
death and worsen injury following neonatal stroke in rodents
(Shimotake et al., 2010).
Studies from the neonatal rat following hypobaric hypoxia
(Kaur et al., 2006a) and MCAO (Mu et al., 2003) have found that
VEGF is up-regulated leading to increased vascular permeability
as well as possibly being neuroprotective.
ERYTHROPOIETIN
Another key hypoxia inducible gene is Epo which, following
hypoxia is increasingly important for regulating red blood cell
production to increase the capacity of red blood cells to trans-
port and ultimately increase oxygen supply (Marti, 2004; Fan
et al., 2009). Hypoxic up-regulation of Epo is regulated by HIF-
1α, however, growing evidence suggests HIF-2α may also play a
significant role is transcriptionally regulating Epo expression in
the brain in vivo and in cultured astrocytes in vitro (Chavez et al.,
2006; Yeo et al., 2008; Fan et al., 2009). Epo is widely expressed
in the brain by astrocytes, neurons, microglia, and endothelial
cells (Bernaudin et al., 1999; Marti, 2004; Castillo-Melendez et al.,
2005). Following cerebral ischemia, endothelial cells are the first
to increase Epo expression (Bernaudin et al., 1999), which could
implicate Epo as being important for the vasculature following
hypoxia. More recently, it has been reported that Epo mediated
angiogenesis can occur by stimulating the expression of VEGF
and its’ receptor on endothelial cells (Iwai et al., 2007; Hermann
and Zechariah, 2009). In vitro, Epo can modulate angiogene-
sis by stimulating endothelial cell migration and proliferation
(Anagnostou et al., 1990; Yamaji et al., 1996).
Suggested to be neuroprotective following hypoxia, increased
Epo expression has also been shown to increase anti-apoptotic
gene expression and promote survival in oligodendrocytes,
neurons, astrocytes, and microglia (Marti, 2004; Fan et al.,
2009). Treatment with recombinant human Epo following focal
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hypoxia-ischemia in neonatal rats results in enhanced revascular-
ization, neurogenesis, endothelial cell and neuronal survival and
increased Glut-1, Tie-1, and angpt-2 expression which resulted in
enhanced neurovascular unit repair (Iwai et al., 2007; Keogh et al.,
2007). Epo treatment following neonatal stroke in rats has also
shown significant neuroprotection (Chang et al., 2005; Gonzalez
et al., 2007).
ANGIOPOIETINS
There is a close interaction between VEGF and angpt (−1 and−2)
expression following hypoxia. Down-regulation of angpt-1,
important for blood vessel stabilization, occurs in response to
hypoxia, and this correlates with increased BBB permeability
and vascular leakage (Zhang et al., 2002b; Valable et al., 2005).
Whether vascular remodeling or regression occurs following cere-
bral ischemia in the adult (rat) is dependent upon the presence of
VEGF. Increased angpt-2 and VEGF expression by blood vessels
promotes vascular growth; however, vascular regression occurs in
the absence of VEGF (Beck et al., 2000). Up-regulation of Tie-1
and Tie-2, the angpt receptors, persists for up to 2 weeks follow-
ing MCAO and this correlates closely with increased angpt-1 and
angpt-2 expression resulting in neovascularization (Lin et al.,
2000, 2001). However, increased angpt-2 expression can also
persist with no change in angpt-1 or Tie-2 expression following
MCAO, or during chronic hypobaric hypoxia in the adult rat
(Beck et al., 2000; Pichiule and LaManna, 2002).
DEGRADATION OF BASAL LAMINA
Degradation of laminin is consistent with disruptions of the
BBB (Figure 3) and can contribute to edema formation and
hemorrhage (del Zoppo and Mabuchi, 2003; Veltkamp et al.,
2006). Degradation of the basal lamina following hypoxia is due
to plaminogen-plasmin system and the MMP-2 and 9. MMPs
belong to a family of proteins that control tissue degradation
(Hamann et al., 1995; Burk et al., 2008). Following hypoxia-
ischemia, MMP-9 is up-regulated, and laminin being a sub-
strate, is thought to result in the laminin degradation that
may then follow (Zalewska et al., 2002). Following ischemia,
decreased collagen IV is associated with increased infarct vol-
ume and changes in BBB permeability (Hamann et al., 1995,
2002; Scholler et al., 2007). However, another basement mem-
brane constituent fibronectin, and its’ α5β1 integrand receptor,
are also up-regulated in endothelial cells following hypobaric
hypoxia in the adult, possibly highlighting an angiogenic role for
this glycoprotein (Milner et al., 2008).
COMPROMISE OF THE BLOOD BRAIN BARRIER
Studies in rodent models of neonatal hypoxia-ischemia have indi-
cated that the BBB is compromised as a result of such insults
(Muramatsu et al., 1997; Svedin et al., 2007; Ferrari et al., 2010b;
Tu et al., 2011; Yang et al., 2012). In addition, CSF samples from
HIE infants have been shown to have albumin CSF/plasma con-
centration ratios that are ∼5 times higher than normal (Kumar
et al., 2008), suggesting a dysfunctional BBB in the HIE infants.
The animal studies have mostly relied on the extravasation of
plasma proteins into brain parenchyma to examine BBB break-
down making the exact timing and magnitude of breakdown
after the insult difficult to ascertain. Ferrari et al. (2010b) who
used sodium fluorescein uptake into the brain to assess barrier
permeability, reported that after hypoxic-ischemic insult in P7
rats there was an increase in BBB permeability at 1 and 7 days
after the insult, but it was restored to normal at 21 days. All
these studies do suggest that hypoxia-ischemia related injury to
the developing brain is associated with compromise to the bar-
rier, however, what role this has in determining the pathological
outcomes is still unclear.
Modification of tight junction proteins may be a cause
of changes to BBB permeability following hypoxia-ischemia
(Figure 3). Malaeb et al. (2007) determined the level of tight
junctional proteins after cerebral ischemia in late gestational
sheep. Cortical samples showed that these proteins were differ-
entially regulated after the insult with higher claudin-5 levels,
but lower ZO-1/2 levels. Adult studies of cerebral ischemia-
reperfusion have also shown that this is associated with changes
to the levels of tight junction proteins in cerebral vessels (Witt
et al., 2003). Studies in rats by Muramatsu et al. (1997) showed
that the BBB was more vulnerable to a hypoxic-ischemic insult
in younger (P7 day) compared to older (P21 day) rat pups, and
as mentioned above, this susceptibility may be related to several
developmental aspects of the formation of the neurovascular
unit. The severity of oxygen deprivation contributes to the rate of
loss of BBB function during acute hypoxic exposure (Al Ahmad
et al., 2009). However, in a model of hypoxia in the newborn
piglet BBB integrity, measured as permeability to small ions, was
maintained (Stonestreet et al., 1992).
Figure 3 summarizes the consequence of hypoxia on the com-
ponents of the neurovascular unit. As mentioned previously,
increased VEGF expression following hypoxia-ischemia results in
compromise of BBB permeability. Synthesis and release of sol-
uble guanylate cyclase, NO, tissue type plasminogen activator,
prostaglandins (PG) and increased calcium influx all contribute
to changes in vascular permeability (Bates and Curry, 1997;
Murohara et al., 1998; Mayhan, 1999; Yang et al., 2009).
Pericytes are some of the first cells to respond to hypoxia,
within the hours following hypoxia in the adult, some pericytes
also migrate away from vessels (Gonul et al., 2002) resulting
in decreased vascular support. In vitro and in vivo studies have
shown that pericytes can express VEGF and exacerbate BBB
disruption following acute hypoxia (Yamagishi et al., 1999; Al
Ahmad et al., 2009, 2011). Pericytes can also express angpt-1,
but whether pericyte migration occurs in the fetal brain following
hypoxia, in regions of BBB compromise could reveal the basis of
vascular fragility (leading to an increased propensity to rupture).
Edema formation
Following hypoxia, BBB leakage triggers the activation of astro-
cytes, corresponding with an increase in AQP4, an astroglial
water channel which facilitates water movement in and out of
the brain, a response that is likely to be involved in the forma-
tion of edema (Kaur et al., 2006b; Ferrari et al., 2010a,b). Two
forms of edema exist; cytotoxic and vasogenic edema. Cytotoxic
edema is swelling of cellular elements and is suggested to occur in
severe cardiovascular and hypoxic collapse seen following pneu-
mothorax (Temesvari et al., 1984; Klatzo, 1987). Vasogenic edema
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FIGURE 3 | Summary of the consequence of hypoxia and/or ischemia
on the neurovascular unit. Following hypoxia, endothelial cells express
a range of key hypoxic and angiogenic factors, basement membrane
degradation occurs, astrocyte end-feet become swollen, modulation of
tight junction expression occur and pericytes may migrate away. These
responses contribute to angiogenesis, vascular remodeling, edema, and
hemorrhage formation, increased vascular permeability, and decreased
vascular stability.
is associated with increased vascular permeability, retention of
water and entry of serum proteins into the brain parenchyma
(Klatzo, 1987). Disruptions in BBB permeability, elevation in
mean arterial blood pressure and subsequent accumulation of
water content into the brain parenchyma all contribute to the for-
mation of vasogenic edema (Kuroiwa et al., 1985; Klatzo, 1987).
Utilizing MRI, clinical studies have found that following severe
perinatal asphyxia more than 80% of term neonates develop
brain edema (Boichot et al., 2006), which has also been shown to
be strongly associated with poor neurological outcome (Chang
et al., 2007). From rodent studies, neonatal hypoxia-ischemia
resulted in a biphasic edema formation occurring initially as
early as 2 h and persisting after 24 h. This was seen to correspond
with an “early” neuronal injury and “late” glial damage (Nedelcu
et al., 1999).
CURRENT CLINICAL THERAPIES AND THE INFLUENCE ON
CEREBRAL BLOOD VESSELS
As well as understanding the response of cerebral blood vessels
following hypoxia-ischemia, it is importantly to briefly detail the
implications of the current clinical therapies given for preterm
birth and possibly reduced injury following hypoxia-ischemia.
GLUCOCORTICOIDS
Prenatal glucocorticoids are routinely administered to women
who are at risk of preterm birth, in an attempt to hasten fetal
lung maturation, especially with respect to surfactant produc-
tion. They have been shown to reduce respiratory distress syn-
drome and intraventricular hemorrhage (Liggins and Howie,
1972; Shankaran et al., 1995). The possible mechanisms that
may contribute to this protection have been elegantly investi-
gated by Vinukonda et al. (2010). They found that glucocor-
ticoid treatment resulted in decreased endothelial proliferation
and vascular density but increased pericyte coverage in the ger-
minal matrix of human preterm infants. In vivo studies in
neonatal rats have shown that dexamethasone treatment prior
to hypoxia-ischemia increased VEGF protein, reducing brain
injury, decreased caspase-3 activity and DNA fragments (Feng
et al., 2011). Interestingly, maternal treatment with glucocorti-
coids such as dexamethasone has shown to also up-regulate key
tight junctional proteins and decrease BBB permeability in the
ovine fetus (Stonestreet et al., 1999; Sadowska et al., 2010), consis-
tent with in vitro studies that also show up-regulation of angpt-1
and down-regulation of VEGF in astrocytes and pericytes fol-
lowing dexamethasone treatment (Kim et al., 2008). However,
dexamethasone treatment had no effect on expression of angpt-1,
-2 or VEGF expression by endothelial cells (Kim et al., 2008). The
implications of these studies are that glucocorticoids, routinely
used to mature the preterm lung, could have direct beneficial
effects on the preterm cerebral circulation. However, it must be
considered also that the greater ease with which preterm neonates
are resuscitated and ventilated may mean that the mechanical
and cardiorespiratory disturbances are lessened, so that wide
fluctuations of cerebrovascular perfusion are somewhat avoided.
HYPOTHERMIA
Brain and/or body cooling is becoming a routine practice for
infants that have suffered birth asphyxia. Hypothermia decreases
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cerebral metabolism, and thereby delays cell death. One study
has shown that following permanent MCAO in the adult rodent,
mild hypothermia resulted in decreased infarct size and enhanced
angiogenesis (Xie et al., 2007). It has been suggested that
hypothermia may therefore, play a beneficial role with regards to
angiogenesis in the sub-acute (hours to days) and chronic (weeks
to months) stages following hypoxia-ischemia (Yenari and Han,
2012). There are also studies indicating that hypothermia restores
BBB function after hypoxia-ischemia, but this seems only to have
been studied after ischemia in the adult. Hypothermia can reduce
the activation of MMPs (Truettner et al., 2005) which can degrade
tight junctional proteins and it can also delay pericyte migration
away from the endothelial cell (Duz et al., 2007).
SUMMARY
This review summarizes current knowledge regarding the
response of the vasculature and the BBB in the fetal and newborn
brain to hypoxia and/or ischemia. Although the studies of the
developing brain are limited in comparison to the adult brain,
the findings indicate that hypoxia-ischemia has significant effects
on the immature cerebral vasculature, perhaps explaining some
of the regional vulnerability of the perinatal brain to injury. The
key mediators of injury mentioned in this review also reveal
great therapeutic potential, not only for early biomarkers of brain
injury, but also for designing clinical treatments that might be
used both prior to or following hypoxia to protect the immature
brain from permanent damage.
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